The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued:
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated – Currently in Shortage)
- Bumetanide Injection, USP (Updated – Currently in Shortage)
- Daclatasvir Tablets (New – Discontinuation)
- Darifenacin Hydrobromide Tablets (New – Discontinuation)
- Dobutamine Hydrochloride Injection (Updated – Currently in Shortage)
- Epinephrine Injection, Auto-Injector (Updated – Currently in Shortage)
- Etoposide Injection (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Guanfacine Hydrochloride Tablets (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketamine Injection (Updated – Currently in Shortage)
- Lamotrigine Tablets (New – Discontinuation)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lorazepam Injection, USP (Updated – Currently in Shortage)
- Meropenem for Injection, USP (New – Discontinuation)
- Methotrexate Sodium Injection (Updated – Currently in Shortage)
- Methyldopa Tablets (New – Currently in Shortage)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Olaparib (LYNPARZA®) Capsules (New – Discontinuation)
- Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
- Perphenazine Tablets (New – Discontinuation)
- Phenytoin Sodium Injection, USP (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Prednisolone Acetate 1% Ophthalmic Suspension (New – Discontinuation)
- Progesterone Injection, USP (Updated – Currently in Shortage)
- Remifentanil (Ultiva) Lyophilized Powder for Solution Injection (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (New – Currently in Shortage)
- Scopolamine Transdermal System (New – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Testosterone 1% Gel (New – Discontinuation)
- Thioridazine Hydrochloride Tablets (Updated – Currently in Shortage)
- Valsartan Tablets (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
